IFNAR1 anticorps (Tyr466) (PE)
Aperçu rapide pour IFNAR1 anticorps (Tyr466) (PE) (ABIN1712792)
Antigène
Voir toutes IFNAR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Tyr466
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human IFNAR1 around the phosphorylation site of Tyr466
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Commentaires
-
Exitation/Emission: 480,565nm/578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 4 °C for 12 months.
-
Date de péremption
- 12 months
-
-
- IFNAR1 (Interferon alpha/beta Receptor 1 (IFNAR1))
-
Autre désignation
- Ifnar1
-
Sujet
-
IFNAR1 is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The encoded protein also functions as an antiviral factor.
Synonyms: Alpha type antiviral protein, AVP, Beta type antiviral protein, CRF2-1, Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1, N alpha REC, N alpha REC, N alpha receptor, N alpha/beta Receptor alpha, N beta receptor, Interferon alpha/beta receptor 1, N-alpha/beta receptor 1, N-R-1, NAR, NAR1, NBR, RC, INAR1_HUMAN, Interferon alpha beta and omega receptor 1, Interferon alpha/beta receptor 1, Interferon alpha/beta receptor alpha chain, Interferon beta receptor 1, Type I interferon receptor 1. -
Pathways
- Signalistation JAK/STAT, Hepatitis C
Antigène
-